Genmab
Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2008-07-01
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- Genmab
- Target Recruit Count
- 8
- Registration Number
- NCT00707655
- Locations
- 🇫🇷
Medical Oncology, Outpatient Clinic, Nantes, France
🇬🇧Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
🇫🇷Centre Georges-Francois Leclerc Hospital, Dijon, France
Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Genmab
- Target Recruit Count
- 9
- Registration Number
- NCT00677924
- Locations
- 🇧🇪
Hospital Erasme, Brussels, Belgium
🇧🇪Institut Jules Bordet, Brussels, Belgium
🇧🇪St-Luc University Hospital, Brussels, Belgium
Zalutumumab in Non-curable Patients With SCCHN
- First Posted Date
- 2007-10-11
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- Genmab
- Target Recruit Count
- 90
- Registration Number
- NCT00542308
- Locations
- 🇺🇸
University Of Chicago Medical Center, Chicago, Illinois, United States
🇦🇹Universitätsklinik für Innere Medizin III, Salzburg, Austria
🇨🇿Nemocnice Jihlava, Jihlava, Czechia
Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2007-04-16
- Last Posted Date
- 2011-12-06
- Lead Sponsor
- Genmab
- Target Recruit Count
- 13
- Registration Number
- NCT00460551
- Locations
- 🇧🇪
CHR La Citadelle, Liege, Belgium
🇳🇱VU Medisch Centrum (VUMC), Amsterdam, Netherlands
🇫🇷CHRU Reims, Hospital Maison Blanche, Reims, Cedex, France
Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer
- Conditions
- Interventions
- First Posted Date
- 2006-11-20
- Last Posted Date
- 2011-12-23
- Lead Sponsor
- Genmab
- Target Recruit Count
- 30
- Registration Number
- NCT00401401
- Locations
- 🇳🇱
Nijmegen University Hospital, Nijmegen, Netherlands
🇸🇪Lund University Hospital, Lund, Sweden
🇫🇷Centre Georges-Francois Leclerc Hospital, Dijon, France
Zalutumumab in Patients With Non-curable Head and Neck Cancer
- Conditions
- Interventions
- First Posted Date
- 2006-09-28
- Last Posted Date
- 2013-10-15
- Lead Sponsor
- Genmab
- Target Recruit Count
- 286
- Registration Number
- NCT00382031
- Locations
- 🇧🇪
Cliniques Saint Pierre, Ottignies, Belgium
🇨🇦Cross Cancer Institute, Edmonton, Alberta, Canada
🇧🇷IBCC - Instituto Brasileiro de Combate ao Câncer, São Paulo, Brazil
Zalutumumab in Head and Neck Cancer
- First Posted Date
- 2004-10-01
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Genmab
- Target Recruit Count
- 28
- Registration Number
- NCT00093041
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen Ø, Denmark
🇩🇰Odense Universitetshospital, Odense, Denmark
🇩🇰Århus Kommunehospital, Århus C, Denmark
Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.
- First Posted Date
- 2003-10-15
- Last Posted Date
- 2023-05-18
- Lead Sponsor
- Genmab
- Target Recruit Count
- 25
- Registration Number
- NCT00071071
- Locations
- 🇺🇸
Stanford University Med. Ctr., Dept. of Dermatology, Stanford, California, United States
🇺🇸University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States
Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.
- First Posted Date
- 2003-10-15
- Last Posted Date
- 2023-04-28
- Lead Sponsor
- Genmab
- Target Recruit Count
- 22
- Registration Number
- NCT00071084
- Locations
- 🇺🇸
Stanford University Med Ctr., Dept of Dermatology, Stanford, California, United States
🇺🇸University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States
Trial With HuMax-CD4 in Participants With Rheumatoid Arthritis (RA) Failing Treatment With Methotrexate (MTX) and a TNF-alpha Blocker
- First Posted Date
- 2002-08-01
- Last Posted Date
- 2023-04-28
- Lead Sponsor
- Genmab
- Target Recruit Count
- 83
- Registration Number
- NCT00042406
- Locations
- 🇺🇸
Arthritis Center of Reno, Reno, Nevada, United States
🇺🇸Rheumatology Associates, P.C., Chicago, Illinois, United States
🇺🇸Advances in Medicine, Rancho Mirage, California, United States